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ABSTRACT
Prevalence, resistance proﬁles, virulence gene
complements, and phylogenetic and clonal afﬁn-
ities of ﬂuoroquinolone-resistant Escherichia coli
from urinary tract infections (UTIs) in Norway
were investigated. Of 7302 E. coli UTI isolates
from 2003, 1.2% were ﬂuoroquinolone-resistant;
35 of these ﬂuoroquinolone-resistant isolates were
included in the present study. The isolates were
predominantly multiresistant, carried few viru-
lence factors, and tended to belong to the less-
virulent phylogroups A and B1. Although the
isolates were genetically heterogeneous, there
was evidence of a limited degree of clonal
dissemination.
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Fluoroquinolone-resistant Escherichia coli (FQREC)
strains have become a major problem in a number
of countries [1,2], but remain infrequent in Nordic
and Baltic countries [3,4], possibly because (as in
Norway) ﬂuoroquinolones are reserved for use
as second-line antimicrobial agents. However,
consumption of ﬂuoroquinolones doubled in
Norway between 1999 and 2006, possibly because
of increasing resistance to ﬁrst-line antibiotics [5].
FQREC isolates tend to be multiresistant, belong
to less pathogenic phylogroups (A and B1), have
fewer virulence factors [6,7], and are reported to
be under-represented in invasive infections [8].
Only limited clonality has been reported [9]. The
aims of the present study were to characterise
uropathogenic isolates of FQREC from Norway,
and to examine the evidence of their clonal
spread.
During 2003, the laboratory at Telemark Bio-
medical Centre, which serves a population of
200 000 in southern Norway, identiﬁed 7302
E. coli isolates from urine specimens. Of these,
84 (1.2%) were ciproﬂoxacin-resistant according
to the disk-diffusion method. Thirty-ﬁve of these
resistant isolates were included in this study; the
remaining 49 isolates were excluded, either
because they were repeat isolates from a single
patient (n = 16), were not conﬁrmed as ﬂuoro-
quinolone-resistant (n = 3), were incorrectly iden-
tiﬁed (n = 2), or were not retained by the
laboratory (n = 14). Twenty-nine (83%) of the 35
isolates studied were from women (age 1–84
years, mean 56 years), and six were from men
(age 61–81 years, mean 70 years). Thirty (86%)
patients resided at home and ﬁve (14%) were
institutionalised.
MICs of ciproﬂoxacin, mecillinam, trimetho-
prim, ampicillin, sulphonamide, nitrofurantoin,
nalidixic acid, chloramphenicol, tetracycline and
gentamicin were determined using Etests (AB
Biodisk, Solna, Sweden), and the isolates were
classiﬁed as sensitive (S), intermediate (I) or
resistant (R) according to the breakpoints recom-
mended by the Norwegian Working Group on
Antibiotics (http://www.antibiotikaresistens.no).
A disk-diffusion test for nalidixic acid resistance
was also performed. Extended-spectrum b-lac-
tamase expression was detected using cefpodox-
ime disks (Oxoid, Basingstoke, UK) in the
presence or absence of clavulanic acid 10 lg,
and was conﬁrmed by Etests with cefotaxime and
ceftazidime, with and without clavulanic acid.
Phylogroup and the presence of virulence factor
genes were determined by multiplex PCR, and
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clonal afﬁnities were assessed by pulsed-ﬁeld gel
electrophoresis (PFGE) as described previously
[10]. PFGE gels were photographed, scanned as
TIFF ﬁles, and then imported into GelCompar
software (Applied Maths, Sint-Martins-Latem,
Belgium). A dendrogram was constructed using
band-based comparisons with the Dice coefﬁcient
and cluster analysis with the unweighted pair-
group method with arithmetic averages
(UPGMA); 1% position tolerance and 3% opti-
misation settings were used. PFGE band patterns
differing by three or fewer bands were classiﬁed
as similar [11]. Statistical analyses were per-
formed using Statistica software (Statsoft Inc.,
Tulsa, OK, USA). The correlation between the
number of virulence factors and antibiotic resis-
tances was tested with the Spearman R-test. The
Mann–Whitney U-test was used to assess differ-
ences in the number of virulence factor genes.
All isolates were resistant to ciproﬂoxacin and
nalidixic acid according to both disk-diffusion
and Etests. Thirty-one (89%) isolates were resis-
tant to ampicillin, 19 (54%) to chloramphenicol,
33 (94%) to tetracycline, 32 (91%) to trimetho-
prim, nine (26%) to gentamicin, eight (23%) to
nitrofurantoin, four (11%) to mecillinam and 35
(100%) to sulphonamide. Two (6%) isolates
expressed extended-spectrum b-lactamases.
Thirty-four (97%) of the isolates were multiresis-
tant (deﬁned as resistance to ﬁve or more agents).
Eight (23%) isolates belonged to phylogroup A
and 11 (31%) belonged to phylogroup B1. Three
(9%) and 13 (37%) isolates belonged to the
urovirulence-associated phylogroups B2 and D,
respectively.
Table 1 shows the distribution of virulence
factors. The FQREC isolates had fewer virulence
factors (p <0.00001) than comparable ﬂuoroqui-
nolone-sensitive isolates [10]; phylogroup A and
B1 isolates had fewer virulence factors than
phylogroup B2 and D isolates (p <0.01). There
was no correlation between the number of
virulence factors and the number of agents to
which the isolates were resistant (p 0.39).
There were 26 PFGE band proﬁles among the
isolates, with 21 isolates having unique PFGE
proﬁles. Five PFGE proﬁles were shared by two to
ﬁve isolates, which, with the exception of groups
22 and 26, had similar resistance and virulence
proﬁles (Table 2). Domicile information revealed
no epidemiological link among patients within
these clonal groups. The PFGE pattern of group
26 resembled that of the clonal group A (CgA)
isolate CCUG55212 [12] (Culture Collection of the
University of Go¨teborg, Go¨teborg, Sweden), but
the isolates with this proﬁle differed from typical
CgA isolates by the absence of papG-II and the
presence of hly.
Overall, the present study revealed that FQREC
isolates are more frequently antibiotic-resistant,
more multiresistant and carry fewer virulence
factors, with a higher proportion of isolates
belonging to phylogroups A and B1 (54%) than
comparable sensitive isolates (13%) from 2001
[10]. However, a shift in the general characteris-
tics of the E. coli population in the 2-year period
between the two studies cannot be entirely
excluded. These ﬁndings are in accord with
previous reports [7,13], as is the ﬁnding that the
isolates are genetically heterogeneous [9]; how-
ever, in contrast to ﬂuoroquinolone-sensitive iso-
lates [10], some evidence of clonal spread was
revealed. It is interesting to note that the two
largest clonal groups belonged to phylogroups B2
and D.
Table 1. Distribution of virulence factors among ﬂuoro-
quinolone-resistant isolates of Escherichia coli belonging to
phylogenetic groups A, B1, B2 and D
Gene
(virulence factor)
A
(n = 8)
B1
(n = 11)
D
(n = 13)
B2
(n = 3)
All
(n = 35)
ﬁmH (type 1 ﬁmbriae) 6 10 11 3 30
papC (P ﬁmbriae) 1 1 6 0 8
papG class I 0 0 0 0 0
papG class II 1 1 6 0 8
papG class III 0 0 0 0 0
draA (Dr haemagglutinin) 0 0 0 0 0
sfaD ⁄E (S ⁄ F1C ﬁmbriae) 0 0 0 0 0
neuB (K1 capsule) 0 0 0 0 0
kﬁC (K5 capsule) 0 0 1 0 1
iutA (aerobactin) 4 6 12 3 25
hlyA (haemolysin) 0 0 1 0 1
Table 2. Properties of clonally related isolates of ﬂuoro-
quinolone-resistant Escherichia coli
PFGE
group
No. of
isolates Phylogroup
Resistance
proﬁle
Virulence
proﬁle
22 5 D sulR, tetR,
(amp, tpm, chl)var
ﬁmH, papC,
pagG-II, iutA
23 3 B2 ampR, sulR, tpmR, tetR,
genvar
ﬁmH, iutA
24 2 B1 ampR, sulR, tpmR, tetR ﬁmH, iutA
25 2 B1 ampR, sulR, tpmR, genR,
(tet, chl)var
ﬁmH, iutA
26 2 D ampR, sulR, tpmR, tetR,
(mec, nit, chl, gen)var
Variable
amp, ampicillin; mec, mecillinam; nit, nitrofurantoin; sul, sulphonamide; tpm,
trimethoprim; tet, tetracycline; chl, chloramphenicol; gen, gentamicin; R, resistant;
var, variable.
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The isolates in this study were depleted in
virulence factors, with the exception of iutA
(aerobactin), which facilitates growth in urine
[14] and was more prevalent (71%) than in
sensitive isolates (39%). The hly gene coding for
haemolysin was found in only one isolate, which
is consistent with previous reports [9] that FQREC
isolates are non-haemolytic. In terms of both
virulence factor proﬁle, which resembles that
reported by Vila et al. [15] and Moreno et al. [7],
and phylogroup distribution, the isolates in the
current study resembled animal faecal isolates [6],
which, in accord with previous ﬁndings [16],
suggests an animal origin of these isolates.
Transmission from animals via food might
account for the presence of disseminated clones.
In conclusion, the present study conﬁrmed that
FQREC urinary tract infection isolates from Nor-
way, where the prevalence of ﬂuoroquinolone
resistance is low (1.2% in this study), are pre-
dominantly multiresistant, carry few virulence
factors and belong to phylogroups associated
with low urovirulence. A limited degree of clonal
dissemination was revealed.
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